✦ LIBER ✦
A phase II trial of taxotere (TXT) 100 or 75 mg/m2 as 2nd line chemotherapy (CT) in patients (PTS) with metastatic breast cancer (mbc) with stratification according to prognosis factors
✍ Scribed by Malik, I.; Roth, A.; Ghilezan, N.; Cufer, T.; Lazarev, A.; Doval, D.; Ionescu-Goga, S.; Chernozemsky, I.; Quinaux, E.; Chirina, N.
- Book ID
- 122082420
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 152 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.